Labor Market Pulse ArchiveSubscribe to a report

Labor Market Pulse · Life Sciences · September 2026

Life Sciences Labor Market Report: Ames, IA MSA — September 2026

Ames life sci pay bends against the national grain.

Ames-area Clinical Research Associate pay has climbed to $100,853 — above the $90,956 national median — even as metro unemployment holds near 2.5%, well under Iowa's 3.2% statewide rate.

Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.

Key indicators

  • Ames MSA unemployment rate: 2.5% — vs 3.2% Iowa statewide, 4.1% national
  • CRA advertised pay, metro vs national: $100,853 vs $90,956 — Metro median now exceeds national median
  • Iowa labor force attrition: -7,500 workers YoY — Largely retirement-driven, per Iowa Workforce Development
  • Iowa WARN-notice affected workers: 3,215 in 2026 — Down 58% from 2025 levels

Key takeaways

Metro CRA pay is outrunning the national trend.

Clinical Research Associate advertised pay rose to a metro median of $100,853, up significantly and now exceeding the national median of $90,956. This inversion suggests Ames-area employers are paying a scarcity premium to retain clinical operations talent locally rather than losing it to larger biotech hubs.

Research Scientist and Biostatistician pay diverge from national patterns.

Metro Research Scientist pay ($104,805) and Biostatistician pay ($110,253) both trail national medians and moved in the opposite direction — Biostatistician fell moderately while the national figure rose. Diverging local and national trajectories for data-dependent roles may reflect smaller, less competitive local hiring pools rather than reduced demand, and warrants recalibration against national benchmarks for any national searches.

Lab Technician pay compression signals a pipeline, not a demand, problem.

Metro Lab Technician pay fell to $41,600, a significant decline tracking a similarly steep national drop. Falling entry-level technician pay alongside tight overall labor supply is consistent with employers substituting automation or outsourcing routine lab work rather than competing for scarce junior talent.

Aging-workforce exits are a quieter threat than layoffs.

Iowa's working population shrank by 7,500 year-over-year, driven largely by retirement, even as WARN-related layoffs fell 58% statewide. For life sciences employers, retirement-driven attrition in manufacturing and regulatory roles may be a more persistent staffing risk than cyclical layoffs over the next several quarters.

Median advertised pay by role — Ames, IA MSA

Life Sciences roles, September 2026. Source: WageScape.
Role25th percentileMedian advertised pay75th percentileMetro trendNational median
Research Scientist *$74,181$104,805$112,429Significant increase$131,354
Clinical Research Associate$57,200$100,853$131,548Significant increase$90,956
Lab Technician$39,269$41,600$47,567Significant decline$47,402
Regulatory Affairs Specialist *$74,639$90,187$103,011Significant increase$104,000
Clinical Data Manager *$74,125$89,187$112,693Significant decline$123,031
Biostatistician *$86,372$110,253$146,269Moderate decline$133,322
Validation Engineer *$118,498$121,331$123,498Significant increase$108,377

* State-level figure shown where metro postings were too few.

WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON

Local market conditions

Ames MSA unemployment sits near 2.5%, well below Iowa's 3.2% statewide rate, with Iowa State University and Mary Greeley Medical Center anchoring a labor pool too small to absorb specialized scientific hiring without displacement from other employers. Statewide retirements are pulling 7,500 workers out of the labor force year-over-year, compounding scarcity for credentialed R&D, regulatory, and quality roles that depend on experienced, not entry-level, talent.

What it means

Tight local labor supply combined with limited biotech concentration — Boehringer Ingelheim Vetmedica remains the metro's primary anchor employer — means Ames-based life sciences operations compete regionally and nationally for regulatory, clinical, and CMC talent rather than drawing from a deep local bench. Metro advertised pay for Clinical Research Associate ($100,853) and Research Scientist ($104,805) trending up while sitting below national medians signals employers may win talent on total rewards structure and role scope rather than base pay alone, but only if they benchmark against national competition, not local peers. Organizations should evaluate whether build-vs-outsource decisions for clinical and CMC functions account for the thinness of the local specialized labor pool, not just cost-per-hire comparisons.

Looking ahead

Early indicator: Watch whether Iowa's new Career Training Physical Expansion Grants (announced September 15) translate into expanded apprenticeship pipelines for QA and manufacturing technicians within the next two quarters — a potential partial offset to retirement-driven attrition.

Worth watching: National regulatory affairs compensation continues climbing ($320K–$580K base for VP-level roles), driven by EU MDR and FDA pathway changes. Ames-area employers without a deep regulatory bench should monitor whether this national pressure pulls senior regulatory talent out of smaller markets.

Emerging pressure point: Statewide manufacturing added 1,300 jobs in August even as WARN-notice volume stayed low, suggesting continued competition for skilled production and quality talent relevant to device and CDMO-adjacent operations in and around Ames.

Potential inflection point: National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions while 64% of surveyed organizations keep recruiting — watch whether any released specialized talent enters the Midwest candidate pool given limited local biotech density.

Methodology

Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.

Free to read and cite with attribution to WageScape. Terms of use.